Recent advances in cell biology, neural injury and repair, and the progress towards development of neurorestorative interventions are the basis for increased optimism. Based on the complexity of the processes of demyelination and remyelination, degeneration and regeneration, damage and repair, functional loss and recovery, it would be expected that effective therapeutic approaches will require a combination of strategies encompassing neuroplasticity, immunomodulation, neuroprotection, neurorepair, neuroreplacement, and neuromodulation. Cell-based restorative treatment has become a new trend, and increasing data worldwide have strongly proven that it has a pivotal therapeutic value in CNS disease. Moreover, functional neurorestoration has been achieved to a certain extent in the CNS clinically. Up to now, the cells successfully used in preclinical experiments and/or clinical trial/treatment include fetal/embryonic brain and spinal cord tissue, stem cells (embryonic stem cells, neural stem/progenitor cells, hematopoietic stem cells, adipose-derived adult stem/precursor cells, skin-derived precursor, induced pluripotent stem cells), glial cells (Schwann cells, oligodendrocyte, olfactory ensheathing cells, astrocytes, microglia, tanycytes), neuronal cells (various phenotypic neurons and Purkinje cells), mesenchymal stromal cells originating from bone marrow, umbilical cord, and umbilical cord blood, epithelial cells derived from the layer of retina and amnion, menstrual bloodderived stem cells, Sertoli cells, and active macrophages, etc. Proof-of-concept indicates that we have now entered a new era in neurorestoratology.
BRIEF PROFILE OF NEURORESTORATOLOGY
neurodegeneration, cerebrovascular anoxia or ischemia, edema, demyelination, sensory and motor disorders, and Definition neuropathic pain, as well as neural damage resulting from toxic, physical, and chemical factors, immune, inNeurorestoratology, a distinct discipline within the neurosciences, has been clearly defined by the Internafectious, inflammatory, hereditary, congenital, developmental, and other intractable neural lesions (376). tional Association of Neurorestoratology as one subdiscipline and one new branch of neuroscience, which studInexorable Law of Neuroscientific Innovation ies the therapeutic strategies for neural regeneration, repair, and replacement of damaged components of the nervous Thousands of years ago (approx 2500 B.C.), spinal cord injuries were described as "crushed vertebra in his system, neuroplasticity, neuroprotection, neuromodulation, angiogenesis, immunomodulation, and their mechneck" as well as symptoms of neurological deterioration without treatment in the ancient Egyptian medical papyanisms to cause improvement. The core of neurorestoratology is to restore neurological function in humans. The rus known as the Edwin Smith Surgical Papyrus by the physician and architect of the Sakkara pyramids Imhotep research field of neurorestoratology covers various neurorestorative treatments including transplantation of tis- (8) . Nearly 90 years ago Ramon y Cajal (1926) stated with certainty: "Once the development was ended, the sue and cells, biomaterials and bioengineering, neuromodulation by electrical and/or magnetic stimulation, founts of growth and regeneration of the axons and dendrites dried up irrevocably. In the adult centers, the pharmaceutical or chemical therapies in neurotrauma, nerve paths are something fixed, ended, and immutable.
potential to restore lost function. Intervention strategies include gene therapy, neurotrophic factors, and cell Everything may die, nothing may be regenerated. It is for the science of the future to change, if possible, this transplantation (195, 248, 321, 377) , tissue engineering (402), and neurostimulation (172, 369) . harsh decree" (51). Regeneration and restoration of the central nervous system (CNS) was thought to be almost Neurorestorative Therapy or Surgery. Intervention an impossibility at that time, although scientists still strategies include cell-based and pharmacological theratried to study the special mystery of human life through pies (423) and electrostimulation (373) . transplanting brain tissues (374) , electrical stimulation
Restorative Neuroscience. Intervention strategies in- (156) , nerve growth factor (NGF) administration (204) , clude cell transplantation, stimulation, and medicine (11). gene therapy (38), and so forth.
Together, all of the medical terms mentioned above Commonly, physicians of traditional clinical disciwere not considered as distinct disciplines, but instead a plines have believed that sequelae of stroke, CNS branch of neurology, neurosurgery, or a specific kind of trauma, neurodegenerative diseases, and damage lack eftherapy. The emergence of the term "neurorestoratolfective treatments. The majority of the medical commuogy," however, signals the birth of a new discipline, nity now still think that: "Our knowledge of the pathowhich is equally important in comparison with neurolphysiological processes, both the primary as well as the ogy and neurosurgery (59). The potential mechanisms of secondary, has increased tremendously. However, all action of neurorestoratology techniques are highlighted this knowledge has only led to improved medical care below. but not to any therapeutic methods to restore, even partially, the neurological function" (8) . Unfortunately, the NEURORESTORATIVE MECHANISMS majority of physicians remain ignorant or unaware of OF CELL THERAPY the increasing quantity of published evidence concernNeuroprotection by Neurotrophins and Immune ing CNS functional restoration by neuromodulation, or Inflammatory Modulation neuroprotection, axon sprouting, neural circuit reconBone marrow mesenchymal stem cells (BM-MSCs) struction, neurogenesis, neuroregeneration, neurorepair, have the capacity to modulate immune/inflammatory reand neuroreplacement in animal models and patients sponses in Alzheimer disease (AD) mice, ameliorating (109, 285, 286, 303, 351, 412) .
their pathophysiology, and improving the cognitive deIt is the eternal desire for humans to prolong and imcline associated with amyloid-β (Aβ) deposits (199) . prove their quality of life, which, with no doubt, it Neural stem/precursor cells (NSPCs) can be used as an should be the instinct and responsibility of physicians immune regulatory tool for autoimmune encephalomyand neuroscientists to search for effective methods. Obelitis (300) . In parallel, olfactory ensheathing cells (OECs) viously, it is inappropriate and overly pessimistic for play a role in neuroprotection through the secretion of physicians to always say that there is no way to help neurotrophins or growth factors (350) . Studies by Chopp patients with the sequelae of diseases and damage to the and colleagues have proven that transplanting MSCs CNS. Therefore, the new discipline, Neurorestoratology, into the brain leads to secretion of neurotrophins, growth is bound to arise from neuroscientific innovation, filling factors and other supportive substances after brain injury in the question-marked frame shown in Figure 1 , which (307), which change the microenvironment in the damaims to create effective therapeutic strategies to benefit aged area and continually facilitate endogenous neuropatients.
restorative mechanisms by reducing apoptotic cell death (55). Garbuzova-Davis et al. (114) 
and Zwart et al. (429) Evolution of Neurorestoratology
reported that an appropriate dose of mononuclear human Restorative Neurology. Dimitrijevic put forward this umbilical cord blood (MNC hUCB) cells may provide a term in 1985. It was defined as the branch of the neuroneuroprotective effect for motor and optic neurons logical sciences that applied active procedures to imthrough the active involvement of these cells in moduprove the functioning of the impaired nervous system lating the host's immune inflammatory system response. through selective structural and functional modification Neural protection afforded by adipose-derived stromal of abnormal neurocontrol according to underlying mechcells was found to be mostly attributable to activated anisms and clinically unrecognized residual functions;
caspase-3 and Akt-mediated neuroprotective pathway its intervention strategies included neurostimulation, signaling through paracrine support provided by trophic neuromodulation, and neuroectomies (83), cell transfactor secretion (393) . plants (242) , drugs (222) , and so on.
Neurogenesis and Angiogenesis Restorative Neurosurgery. This term was put forward by Liberson in 1987 (221) . Then restorative neuroIn early animal studies using neural stem cell treatments, very few cells become neurons (53) and it was surgery, as the frontier of neurosurgery, provided the believed that there was no evidence that "new" neurons neuronal subtypes, establish synaptic contact with host cells, increase the expression of synaptic markers, and could reinnervate muscle (256) . More studies now indicate that mesenchymal stromal cells (137, 206) Our clinical study showed that patients with chronic tract resulting in the recovery of neurological functions spinal cord injury have rapid recovery of some functions in acute (44, 211, 312, 314, 409) as well as chronic spinal following OEC transplantation. The explanation is that injury (267) .
they changed the local microenvironment by the secreNeural Circuit or Network Reconstruction, tion of useful chemicals or growth factors, which can Neuroplasticity, and Neuroreplacement promote the nerve cell growth, unmasking the quiescent axons, and therefore restoring some of the lost functions In the rat stroke model, a graft of medial ganglionic eminence (MGE) cells may differentiate into multiple (147). Grafting dental pulp stem/stromal cells (DPSC)
can promote proliferation, cell recruitment, and maturaalternative therapy for a variety of degenerative and traumatic disorders (Table 1) . It has been argued that tion of endogenous stem/progenitor cells by modulating the local microenvironment through enhancing ciliary neural transplantation can promote functional recovery by the replacement of damaged nerve cells, the reestabneurotrophic factor (CNTF), vascular endothelial growth factor (VEGF), and fibroblast growth factor (FGF) as lishment of specific nerve pathways lost as a result of injury, the release of specific neurotransmitters, or the stimulators and modulators of the local repair response in the CNS (142) and neuromodulation would likely be production of factors that promote neuronal growth (260,343,360). necessary to realize the full potential of NSC grafts in restoring function (111) . Another study also suggested Fetal/Embryonic Spinal Cord Tissue that the inhibitory neurotransmitters γ-aminobutyric acid (GABA) and glycine secreted by transplanted cells
The first successful transplantation of fetal spinal cord into adult spinal cord was reported in 1983 (291). could be an effective clinical tool for treating spinal cord injury (SCI)-associated neuropathic pain (91).
Some topographical features of the normal spinal cord may be represented in mature spinal cord transplants Generally, the patient's functional restoration originated from some or all of the mechanisms as listed (318). Embryonic spinal cord transplants are capable of replacing damaged intraspinal neuronal populations and above. But under many conditions, functional recovery is from neuromodulation or unmasking, neuroprotection, restoring some degree of anatomical continuity between the isolated rostral and caudal stumps of the injured sprouting, neural circuit reconstruction, and neuroplasticity by neurotrophins, immune or inflammatory modumammalian spinal cord (317) . Improved hind limb behavioral deficits were observed after fetal spinal cord lation and local microenvironment change, and in a few cases from neurogenesis or neuroregeneration, and neurhomografts (31). Moreover, the grafted fetal/embryonic tissue may stimulate partial regression of an established orepair (378, 409) . Neuroreplacement may be an important tool for Parkinson's disease (PD), but may not be a glial scar (141) , replace missing motoneurons (353) , and form myelin (324 398, 419) . The cellular composition of the olfactory tissue and the evidence that equivalent observed both in the lateral ventricle and inside the parenchyma, 30 and 110 days after transplant. They differcell types exist in both rodent and human olfactory mucosa suggest that it is potentially a rich source of autoloentiated into organotypical and histotypical structures and cells similar to those formed in normal developgous cells for transplant-mediated repair of the CNS (224) . Selected relevant studies are listed in Table 2 . ment. Nerve and glial cells of these transplants were well differentiated and tightly connected with the surSchwann Cells rounding nervous tissue of the host (7) . It has been convincingly shown that grafting of fetal/embryonic brain Schwann cells (SCs) play a pivotal role in the maintenance and regeneration of the axons in the peripheral cells/tissue into the brain and/or spinal cord is a useful nervous system (PNS) due to their ability to dedifferenti-SC migration and myelination is mediated by interactions between sets of extracellular matrix molecules with ate, migrate, proliferate, express growth-promoting factors, and myelinate-regenerating axons (197) . Further, cell surface preoteins, genetic engineering of SCs to alter aspects of these interactions is a possible way forSCs have been shown to form myelin after transplantation into the demyelinated CNS. They can remyelinate ward. Efforts are, therefore, focused on enhancing their migration and functional integration into the lesioned spinal cord lesions after experimental demyelination, leading in some cases to functional recovery in rodent CNS. In addition, efforts are under way to use these cells as tissue engineer seeds and gene delivery vehicles and primate models (154) . However, SCs do not normally enter the CNS, and migration of SCs transplanted for an array of molecules with repair potential (33,282). The SCs ability to promote restorative efforts has led to into the CNS white matter is inhibited by astrocytes. As can provide an environment beneficial to the promotion cated that there are differences in the ability of immature of regeneration of sensory axons, possibly by the release and mature astrocytes to facilitate plastic changes in the of cytokines and interaction with other nonneuronal cells adult brain. Immature astrocytes can synthesize trophic in the immediate vicinity (117, 305) . factors to support neuronal survival, produce a permissive environment for neurite extension, and reduce scar Purkinje Cells formation. In contrast, mature astrocytes produce a nonPurkinje cells have a therapeutic value for the repermissive environment for axon growth and increase placement and reconstruction of a defective cerebellar scar formation. Purified astrocytes were capable of facilcircuitry in heredodegenerative ataxia. Insignificant itating behavioral recovery from frontal cortex ablation, amelioration of motor skills was found in mice after demyelinating lesions in spinal cord, and kainic acid solid cerebellar tissue transplantation, while the cell sus-(KA) lesions of the striatum (10, 104, 174, 240, 392) . Impension application had no effect (344, 357, 358) . planted cultured immature astrocytes can stimulate axonal regeneration after injury of the postcommissural forTanycyte nix tract in the adult rat brain (406). In addition, Tanycytes (TAs) are the specialized ependymal glia behavior alleviation after astrocyte transplantation was in the CNS, which are located mostly in the ventral wall shown in rat models of memory deficit induced by of the third ventricle and median eminence (ME). They alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic closely interact with local cerebrospinal fluid, blood, and acid lesions, which is independent of cholinergic recovneurons. TA is a common component of the brain barery. The cultured astrocytes may exert their effects over rier system, the brain-cerebrospinal fluid (CSF) neuroa short time period (less than 2 weeks) around the lesion humoral circuit, and the immune-neuroendocrine netsite. They can alter the microenvironment and as a result work. Recent data indicate that TAs transplanted into less scar tissue was formed followed by less of a barrier the adult rat spinal cord can support the regeneration of to the regrowth of nerve fibers (43). Furthermore, evilesioned axons and may represent a useful therapeutic dence indicates that astrocytes at an immature stage of tool for CNS diseases (306) . differentiation are capable of inducing axon growth from the adult optic nerve (354) .
Dopaminergic Neurons Microglia
Intracerebral transplantation of dopaminergic (DAergic) neuron/cells is currently performed as a restorative Microglia are the principal immune cells in the CNS and are characterized by a highly specific morphology therapy for PD (273) . The success of cell therapy in PD 
Cholinergic Neurons
Transplantation of NSCs or their derivatives into a host Transplanted cholinergic neurons may reinnervate the brain and the proliferation and differentiation of endogehost hippocampus, although this reinnervation appears nous stem cells by pharmacological manipulations are to be different from that seen in the intact hippocampal promising treatments for many neurodegenerative disformation (9). Intraretrosplenial cortical grafts of cholineases and brain injuries, such as PD, brain ischemia, and ergic neurons can become functionally incorporated SCI (Table 4) . with the host neural circuitry, and the activity of the Bone Marrow Stromal Cells implanted cholinergic neurons can be modulated by the host brain (216) and it can rectify spatial memory defiBone marrow stromal (also called "stem") cells (BMSCs) can be easily amplified in vitro and their transcits produced by the loss of intrinsic cholinergic afferents from the medial septal nucleus (217) . Reconstruction of differentiation into neural cells has been claimed in vitro and in vivo (63,82,163,171). The possible mechanisms the septohippocampal pathways by axons extending from embryonic cholinergic neuroblasts grafted into the responsible for the beneficial outcome observed after BMSC transplantation into neurodegenerating tissues inneuron-depleted septum has been confirmed in the neonatal rat (198) . Intrahippocampal septal grafts are able clude cell replacement, trophic factor delivery, immunomodulation, and anti-inflammatory, neuroprotection, and to reinnervate the hippocampal formation and ameliorate spatial learning and memory deficits, which are associangiogenesis (171,371,379). Transplantation of BMSCs may have a therapeutic role after SCI (64). Adult BMSCs ated with anatomical and functional incorporation into the circuitry of the host hippocampal formation. Autoadministered intravenously have been shown to migrate into the brain and improve neurological outcome in rats transplantation of peripheral cholinergic neurons into the cerebral cortex displayed amelioration of abnormal bewith traumatic brain injury (236) . In parallel, data of intracerebral transplantation suggest that bone marrow havior in AD (160). could potentially be used to induce plasticity in ischemic MSC therefore could be a viable alternative to human ES cells or NSCs for transplantation therapy of CNS brain. Additionally, cotransplantation of BMSCs with ES cell-derived graft cells may be useful for preventing trauma and neurodegenerative diseases (235) ( Table 6 ). the development of ES cell-derived tumors (253) . ReUmbilical Cord Blood Cells sults of this field are summarized in Table 5 .
UCB is a rich source of stem cells with great proliferUmbilical Cord Mesenchymal Stromal Cells ative potential, besides the bone marrow and peripheral blood; it has the advantage of being an easily accessible Mesenchymal stromal cells (MSCs) have now been isolated from most tissues, including the umbilical cord stem cell source and is less immunogenic compared to other sources for stem cells (334). There are at least (UC) and UC blood (UCB; see below). UC and UCB MSCs are more primitive than those isolated from other three kinds of stem cells in UCB: hematopoietic, mesenchymal, and embryonic-like stem cells, which are capatissue sources and do not express the major histocompatibility complex (MHC) class II human leukocyte antible of differentiating across tissue lineage boundaries into neural, cardiac, epithelial, hepatocytic, and dermal gen-D-related (HLA-DR) antigens. Studies have shown that UC MSCs are still viable and are not rejected 4 tissue both in vitro and in vivo (132, 325, 383) . Increasing evidence suggests that MSCs from UCB are present months after transplantation as xenografts, without the need for immune suppression, suggesting that they are a within a wide range of tissues and its therapeutic potential extends beyond the hematopoietic component (34). favorable cell source for transplantation (422) . UC including arteries (UCA), veins (UCV), and Wharton's
The expanding population of NSPCs can be selected from the human cord blood nonhematopoietic (CD34-jelly (UCWJ) is a convenient, efficient source of MSCs that can be expanded easily in vitro for numerous clininegative) mononuclear fraction (49). UCB can be a potential source for autologous or allogeneic monocytes/ cal applications for the treatment of nonhematopoietic diseases, and in studies of tissue regeneration and immumacrophages. UCB monocytes should be considered as a primary candidate owing to their easy isolation, low nosuppression (119,159). UC MSCs have proven to be efficacious in reducing lesion sizes and enhancing beimmune rejection, and multiple characteristic advantages such as their anti-inflammatory properties by havioral recovery in animal models of ischemic and traumatic CNS injury. Recent findings also suggest that virtue of their unique immune and inflammatory immaturity, and their proangiogenic ability (333) . The theraneurons derived from UC-MSC could alleviate movement disorders in hemiparkinsonian animal models. UCpeutic potential of UCB cells may be attributed to the inherent ability of stem cell populations to replace dam-1995 based on favorable results in animal models including EAE (47). Recent studies show that transplantaaged tissues. Alternatively, various cell types within the graft may promote neural repair by delivering neural tion of HSCs from bone marrow is an effective strategy for SCI after directly transplanting cells into the cord protection and secretion of neurotrophic factors (284, 334). In addition, evidence suggests that delivery of cir-1 week after injury (185) , with a similar potential in comparison with marrow stromal cells (180) . An inculating CD34
+ human UCB cells can produce functional recovery in an animal stroke model with concurrent angiogenesis and neurogenesis leading to some + creasing number of studies provide evidence that hemamyelinated endogenous host axons, recruited endogenous SCs into the injured cord, formation of a bridge topoietic stem cells, either after stimulation of endogenous stem cell pools or after exogenous hematopoietic across the lesion site, increased size of the spared tissue rim, myelinated spared axons within the tissue rim, restem cell use, improve functional outcome after ischemic brain lesions. Various underlying mechanisms such duced reactive gliosis, and an environment that was highly conducive to axonal growth (35). In addition, as transdifferentiation into neural lineages, neuroprotection through trophic support, and cell fusion have been SKPs transplanted into PD model rats sufficiently differentiated into dopamine neuron-like cells, and partially deciphered (130) . Furthermore, intracerebral peripheral blood hematopoietic stem cell (CD34 + ) implantation inbut significantly corrected their behavior. The generated DA neuron-like cells are expected to serve as donor cells duces neuroplasticity by enhancing β1 integrin-mediated angiogenesis in chronic cerebral ischemia with signififor neuronal repair for PD (188) . Thus, this cell line has been identified as novel, accessible, and a potentially cantly increased modulation of neurotrophic factor expression in the ischemic hemisphere (352) .
autologous source for future nervous system repair (35,192).
Adipose-Derived Adult Stem/Precursor Cells
Retinal Pigment Epithelial Cells Adipose tissue is an abundant, accessible, and replen-
The retinal pigment epithelium consists of a unicelluishable source of adult stem cells that can be isolated lar layer of neuroepithelial cells, retinal pigment epithefrom liposuction waste tissue by collagenase digestion lial (RPE) cells, which are essential for the maintenance and differential centrifugation (118) . These adiposeof the normal function of the retina (139) . Cultured huderived adult stem (ADAS) cells, which exhibit characman RPE cells have the capacity to synthesize neuroteristics of multipotent adult stem cells, similar to those trophins, including NGF, brain-derived growth factor of MSCs, are multipotent, differentiating along the adi-(BDNF), glial cell-derived neurotrophic factor (GDNF), pocyte, chondrocyte, myocyte, neuronal, and osteoblast and neurotrophin-3
(NT-3) (158,262). Studies have lineages (124). ADAS cells have potential applications
shown that, as an alternative cell source, RPE cells posfor the repair and regeneration of acute and chronically sess DAergic replacement properties with neurotrophic damaged tissues (329) . As an alternative stem cell support on primary cultures of rat striatal (enkephalinersource for CNS therapies, ADAS cells labeled with sugic) and mesencephalic (DAergic) neurons, and thereperparamagnetic iron oxide have been shown using MRI fore could exert a positive effect in parkinsonian animals to successfully transplant in vivo in unilateral middle by intrastriatal transplantation (247,257,365,366). RPE cerebral artery occluded (MCAo) mice (320) . The study cells can be transduced with high efficiency using an of Ryu and colleagues indicate that improvement in neuadenoviral vector, making them promising vehicles for rological function by the transplantation of ADAS in local delivery of therapeutic proteins for the treatment dogs with SCI may be partially due to the neural differof neurodegenerative diseases in a combined cell and entiation of the implanted stem cells (326) . Furthermore, gene therapeutic approach (14). the transplantation of ADAS can promote the formation of a more robust nerve in rats with a sciatic nerve defect Amniotic Epithelial Cells and produce a decrease in muscle atrophy (336).
Human amniotic epithelial cells (AEC) do not express the HLA-A, -B, -C, or -DR antigens on their surSkin-Derived Precursors face, which suggests no acute rejection in transplantaSkin-derived precursors (SKPs) are a self-renewing, tion (6) . The human amnion membrane serves as a multipotent precursor that are generated during embryobridge for axonal regeneration in vitro and in vivo; cells genesis and persist into adulthood in the dermis, share isolated from the amniotic membrane can differentiate characteristics with embryonic neural crest stem cells, into all three germ layers, have low immunogenicity and including their ability to differentiate into neural crestanti-inflammatory function (76,417). Given their multiderived cell types such as peripheral neurons, SCs, potent differentiation ability, capability of synthesizing astrocytes, and endothelium (26,149). After transplantacatecholamines including DA, and neurotrophic and tion, the cells yield healthy cells that migrate to the leneuroprotection effect, there is accumulating evidence sion site, and then differentiate mainly into cells exthat suggests that AECs have therapeutic potential for pressing glia and neuronal markers (122 (380); subsequent Sertoli Cells evidence shows that populations of stromal stem cells derived from menstrual blood are multipotent, being
Transplanted testis-derived Sertoli cells, which create a localized immune "privileged" site, possess a modulaable to differentiate into chondrogenic, adipogenic, osteogenic, neurogenic, and cardiogenic cell lineages (290) .
tory function on graft rejection and survival and act as a viable graft source for facilitating the use of xenotransThe cultured menstrual blood express embryonic likestem cell phenotypic markers [Octamer-4 (Oct4), stageplantation for diabetes, PD, Huntington's disease, and other neurodegenerative diseases (41,331,332). In addispecific embryonic antigen (SSEA), Nanog], and when grown in appropriate conditioned media, express neution to producing immunoprotective factors, Sertoli cells also secrete growth and trophic factors that appear to ronal phenotypic markers [nestin, microtubule-associated protein 2 (MAP2)] (40). Transplantation of menenhance the posttransplantation viability of isolated cells and, likewise, the postthaw viability of isolated, cryoprestrual blood-derived stem cells, either intracerebrally or intravenously and without immunosuppression, signifiserved cells (52). Sertoli cells grafted into adult rat brains ameliorated behavioral deficits and enhanced cantly reduces behavioral and histological impairments in adult ischemic stroke rats (40).
DAergic neuronal survival and outgrowth (331) . Cotrans-planting of Sertoli cells may be useful as a combination younger, but not in older patients (108) . Furthermore, pathologic findings suggest that grafts of fetal mesencetherapy in CNS lesions, a strategy that could enhance the recovery benefits associated with transplantation and phalic DA neurons could survive long term with or without α-synuclein-positive Lewy bodies (184, 205, 259) . decrease the need for, and the risks associated with, long-term systemic immunosuppression (399) . Further, Bachoud-Lévi and coworkers indicated motor and cognitive recovery in patients with Huntington's disease recent research has shown that implantation of a Sertoli cell-enriched preparation has a significant neuroprotecafter neural transplantation (17), which continued during long-term follow-up (16). The therapeutic value of hutive benefit to vulnerable motor neurons in a superoxide dismutase 1 (SOD1) transgenic mouse model of amyoman striatal neuroblasts in Huntington's disease was identified by Gallina and colleagues (112). trophic lateral sclerosis (ALS) (136) .
Induced Pluripotent Stem Cells
Human Neural Stem/Progenitor Cells Induced pluripotent stem (iPS) cells are derived from or Neuronal Cells somatic cells by ectopic expression of a few transcrip-
The clinical regimes of intracranial implant of human tion factors. iPS cells appear to be able to self-renew neuronal cells in stroke patients have proven safe and indefinitely and to differentiate into all types of cells feasible, though there is a lack of evidence for a signifiin the body, and are almost identical to ES cells. The cant benefit in motor function (181, 182) . Data suggest generation of patient-derived pluripotent cells applicable that cell therapy is a safe method and can be effectively to autologous cell-based therapies has the potential to used for stroke (308) , acute brain injury (346, 347) , and revolutionize medicine (60). Since the first report from cerebral palsy (345). In addition, neurological function Takahashi and Yamanaka on the reprogramming of has been restored after autologous neural stem cell transmouse fibroblasts into pluripotent stem cells by defined plantation in patients with brain trauma (428) . Umbilical Cord Blood Mesenchymal Stem Cells restoration of auditory spiral ganglion neurons suggest a new avenue for highly effective, tumor-free, and imKang and colleagues report that UCB-MSC transmune rejection-free cell therapy for PD, SCI, and hearplantation may play a role in the treatment of SCI paing disturbance in the near future (151, 276, 323) .
tients (169) .
CLINICAL STUDIES OF CELL-BASED Olfactory Ensheathing Cell and Olfactory
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Mucosa Autografts IN CNS DISEASES (TABLE 9)
Early OEC/olfactory mucosa autograft transplants for Adrenal Medullary Tissue, Substantia Nigra, patients with chronic SCI were reported by Huang et al. shown in chronic SCI, ALS, cerebral palsy, stroke, MS, provided a modest improvement in motor function and and other neurodegenerative diseases and traumatic have clinically valuable improvements in most recipibrain insults in 1,255 patients (144,145). ents within a period of long-term follow-up after transplantation into the brain of patients with PD. Freed and Schwann Cells colleagues randomly assigned patients to receive nerve cell transplants or sham surgery with double-blind folData from Arjmand and colleagues suggested that autologous SC transplantation is safe for spinal cord inlow-up. The result showed that transplanted human embryonic DA neurons survive with clinical benefit in jured patients but had no beneficial effects (327). obvious neurologic improvement for patients with polycells derived from donor hematopoietic stem cells were neuropathy, organomegaly, endocrinopathy, M-protein, able to enter the human CNS primarily at sites of motoand skin changes syndrome (190, 191) . neuron pathology and engrafted as immunomodulatory cells, but they did not provide benefit in sporadic ALS SUMMARY AND PROSPECTS patients (12). On the contrary, autologous anti-human CD133 + mononuclear cell transplantation in the motor When entering the 21st century, numerous centers have globally started clinical trials or experimental treatcortex delays ALS progression and improves quality of life (251) . Furthermore, many studies showed that this ments to investigate the utilization of cells, such as neurons, OECs, bone marrow-derived cells, NSPCs, SCs, kind of cell therapy was feasible, safe, and effective for ALS (78), stroke (21,364), chronic SCI patients (61,77, etc., for intractable CNS diseases. Despite their diversity in number, clinical status of subjects, route of cell ad-266,287,368), and there was also improvement in the acute and subacute phase of chronic SCI (416) . Different ministration, and criteria to evaluate efficacy, the main conclusion drawn from these clinical studies was that routes of cell transplantation such as by direct injection into spinal cord, intravenous and intrathecal injection such therapies were safe, feasible, and had some neurological functional improvement or restorative effect that have proven to be equally effective in SCI (116) and traumatic brain injury (424). Evidence shows that autolimproved the patient's quality of life to a varying extent. These achievements had already answered YES or NO ogous hematopoietic stem cell transplantation cannot be deemed a curative treatment but instead may give rise to the question of whether the degeneration and damage in the CNS could be functionally restored. to prolonged stabilization or change the aggressive course of diseases (330 
